Tirzepatide GLp-1 + GIP Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptors, giving your body two powerful pathways to regulate appetite, metabolism, and blood sugar
The FDA approval was based on rigorous clinical trials (the STEP trials), which showed that the benefits of the medication in reducing weight and strictly associated health risks like heart disease and diabetes generally outweigh the risks for the intended population
Its expansion into NASH, CVD, neurodegenerative diseases, and obesity-related cancers could redefine chronic disease management, offering a single therapy with multifaceted benefits
10.3109/15376516.2010.550016 24 DokumaciogluE.skenderH.AktasM.HanedanB.DokumaciogluA.SenT.et al (2017)
Thats why people turn to supplements or treatments like IV drips to boost their glutathione levels again